Sensitivity and specificity of autoantibody tests in the differential diagnosis of lupus nephritis

Abstract

Several studies have investigated the potential of various autoantibody tests in the diagnosis of systemic lupus erythematosus (SLE). Many lupus patients initially present with glomerulonephritis. In that clinical situation the main differential diagnosis are other forms of glomerulonephritis. In this study the diagnostic value of nine test kits for autoantibody against ANA, dsDNA, circulating immune complexes, C1q, nucleosomes, histones and Sm as well as C3 and C4 levels was evaluated in 39 patients with biopsy-proven lupus nephritis in comparison to 43 patients suffering from other forms of glomerulonephritis. The most useful test was an anti-nucleosome antibody enzyme-linked immunosorbent assay (ELISA) with a sensitivity of 90% and a specificity of 88%. All tests for anti-dsDNA antibodies (Crithidia luciliae Anti-dsDNA, BINDAZYME Anti-dsDNA, FARRZYME high avidity Anti-dsDNA) were of moderate sensitivity and very good specificity. Decreasing the cut-off for the conventional anti-dsDNA ELISA (BINDAZYME) considerably increased its sensitivity (87%) without loss of specificity (90%). Tests for anti-C1q and immune complexes performed worse than the antidsDNA tests. As anti-histone and Sm antibodies are present only in a minority of lupus nephritis patients they are of limited value in diagnosing the disease. In conclusion, testing for anti-nucleosome antibodies and the conventional anti-dsDNA ELISA with lower cut-off provide the best diagnostic aids for differentiation of lupus nephritis from other forms of glomerulonephritis. Lupus (2009) 18, 1276—1280.

Keywords

anti-DNA antibodies nephritis renal lupus

Get full access to this article

View all access options for this article.

References

Hochberg MC , Boyd RE , Ahearn JM , et al. Systemic lupus erythematosus: a review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets. Medicine (Baltimore) 1985; 64: 285-295.

Estes D. , Christian CL The natural history of systemic lupus erythematosus by prospective analysis . Medicine (Baltimore) 1971; 50: 85-95.

Tan EM , Cohen AS , Fries JF , et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.

Egner W. The use of laboratory tests in the diagnosis of SLE. J Clin Pathol 2000; 53: 424-432.

Okamura M. , Kanayama Y. , Amastu K. , et al. Significance of enzyme linked immunosorbent assay (ELISA) for antibodies to double stranded and single stranded DNA in patients with lupus nephritis: correlation with severity of renal histology. Ann Rheum Dis 1993; 52: 14-20.

Mortensen ES , Fenton KA , Rekvig OP Lupus nephritis: the central role of nucleosomes revealed. Am J Pathol 2008; 172: 275-283.

Deshmukh US , Bagavant H. , Fu SM Role of anti-DNA antibodies in the pathogenesis of lupus nephritis. Autoimmun Rev 2006; 5: 414-418.

Grootscholten C. , Dieker JW , McGrath FD , et al. A prospective study of anti-chromatin and anti-C1q autoantibodies in patients with proliferative lupus nephritis treated with cyclophosphamide pulses or azathioprine/methylprednisolone. Ann Rheum Dis 2007; 66: 693-696.

Trendelenburg M. , Lopez-Trascasa M. , Potlukova E. , et al. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis . Nephrol Dial Transplant 2006; 21: 3115-3121.

10.

Swaak AJ , Aarden LA , Statius van Eps LW , et al. Anti-dsDNA and complement profiles as prognostic guides in systemic lupus erythematosus. Arthritis Rheum 1979; 22: 226-235.

11.

Aarden LA , de Groot ER , Feltkamp TE Immunology of DNA. III. Crithidia luciliae, a simple substrate for the determination of anti-dsDNA with the immunofluorescence technique. Ann N Y Acad Sci 1975; 254: 505-515.

12.

Aitkaci A. , Monier JC , Mamelle N. Enzyme-linked immunosorbent assay for anti-histone antibodies and their presence in systemic lupus erythematosus sera. J Immunol Methods 1981; 44: 311-322.

13.

Brinkman K. , Termaat R. , Van den Brink H. , et al. The specificity of the anti-dsDNA ELISA. A closer look. J Immunol Methods 1991 ; 139: 91-100.

14.

Gutierrez-Adrianzen OA , Koutouzov S. , Mota RM , et al. Diagnostic value of anti-nucleosome antibodies in the assessment of disease activity of systemic lupus erythematosus: a prospective study comparing anti-nucleosome with anti-dsDNA antibodies. J Rheumatol 2006; 33: 1538-1544.

15.

Horak P. , Hermanova Z. , Zadrazil J. , et al. C1q complement component and -antibodies reflect SLE activity and kidney involvement. Clin Rheumatol 2006 ; 25: 532-536.

16.

Marto N. , Bertolaccini ML , Calabuig E. , et al. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus. Ann Rheum Dis 2005; 64: 444-448.

17.

Moroni G. , Trendelenburg M. , Del Papa N. , et al. Anti-C1q antibodies may help in diagnosing a renal flare in lupus nephritis. Am J Kidney Dis 2001; 37: 490-498.

18.

Cortes-Hernandez J. , Ordi-Ros J. , Labrador M. , et al. Antihistone and anti-double-stranded deoxyribonucleic acid antibodies are associated with renal disease in systemic lupus erythematosus. Am J Med 2004; 116: 165-173.

19.

Jaekell HP , Trabandt A. , Grobe N. , et al. Anti-dsDNA antibody subtypes and anti-C1q antibodies: toward a more reliable diagnosis and monitoring of systemic lupus erythematosus and lupus nephritis. Lupus 2006; 15: 335-345.

20.

Ravirajan CT , Rowse L. , MacGowan JR , et al. An analysis of clinical disease activity and nephritis-associated serum autoantibody profiles in patients with systemic lupus erythematosus: a cross-sectional study. Rheumatology (Oxford) 2001; 40: 1405-1412.

21.

Bigler C. , Lopez-Trascasa M. , Potlukova E. , et al. Antinucleosome antibodies as a marker of active proliferative lupus nephritis. Am J Kidney Dis 2008; 51: 624-629.

22.

Kramers C. , Hylkema MN , van Bruggen MC , et al. Anti-nucleosome antibodies complexed to nucleosomal antigens show anti-DNA reactivity and bind to rat glomerular basement membrane in vivo . J Clin Invest 1994; 94: 568-577.

23.

Kalaaji M. , Fenton KA , Mortensen ES , et al. Glomerular apoptotic nucleosomes are central target structures for nephritogenic antibodies in human SLE nephritis. Kidney Int 2007; 71: 664-672.

24.

van Bavel CC , van der Vlag J. , Berden JH

Glomerular binding of anti-dsDNA autoantibodies: the dispute resolved?

Kidney Int 2007; 71: 600-601.